T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis
- 29 April 2011
- journal article
- Published by Elsevier in Tuberculosis
- Vol. 91 (4), 308-313
- https://doi.org/10.1016/j.tube.2011.04.001
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infectionProceedings of the National Academy of Sciences, 2010
- Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosisProceedings of the National Academy of Sciences, 2010
- The PD‐1 pathway in tolerance and autoimmunityImmunological Reviews, 2010
- Evaluation of Standard Chemotherapy in the Guinea Pig Model of TuberculosisAntimicrobial Agents and Chemotherapy, 2010
- Role of PD-1 in regulating acute infectionsCurrent Opinion in Immunology, 2010
- TIM‐3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokinesEuropean Journal of Immunology, 2009
- Influence ofMycobacterium bovisBCG Vaccination on Cellular Immune Response of Guinea Pigs Challenged withMycobacterium tuberculosisClinical and Vaccine Immunology, 2008
- Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fatesThe Journal of Experimental Medicine, 2008
- Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapyClinical and Experimental Immunology, 2006
- Early Events in Mycobacterium tuberculosis Infection in Cynomolgus MacaquesInfection and Immunity, 2006